Compare BIAF & HCTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIAF | HCTI |
|---|---|---|
| Founded | 2014 | 2020 |
| Country | United States | United States |
| Employees | 57 | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6M | 3.9M |
| IPO Year | N/A | 2021 |
| Metric | BIAF | HCTI |
|---|---|---|
| Price | $0.70 | $1.73 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 559.5K | 82.3K |
| Earning Date | 05-14-2026 | 04-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $13,891,000.00 |
| Revenue This Year | $20.95 | $79.33 |
| Revenue Next Year | N/A | $20.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 18.77 |
| 52 Week Low | $0.23 | $0.01 |
| 52 Week High | $13.50 | $20.42 |
| Indicator | BIAF | HCTI |
|---|---|---|
| Relative Strength Index (RSI) | 24.49 | 39.02 |
| Support Level | $0.69 | $1.70 |
| Resistance Level | $0.87 | $2.57 |
| Average True Range (ATR) | 0.05 | 0.15 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 33.58 | 14.29 |
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.
Healthcare Triangle Inc is a healthcare information technology company focused on advancing industry-transforming solutions in the sectors of cloud services, data science, and professional and managed services for the healthcare and life sciences industry. The company reinforces healthcare progress through technology and extensive industry know-how. HTI supports healthcare providers and payors, hospitals, and Pharma Life Sciences organizations in their efforts to improve health outcomes by enabling the adoption of new technologies, data enlightenment, business agility, and accelerated response to immediate business needs and competitive threats. It provides services under three operating segments: Software Services, Managed Services, and Support and Corporate & others.